Targets › MIR-126
1 program from 1 company in 1 trial: 1 Phase 1; Other.
Open in Phaseline: the race on MIR-126, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Universitas Padjadjaran | Mesenchymal Stem Cell-Derived Exosomes Exosomes containing bioactive molecules (microRNAs including miR-126-3p, proteins, and lip | MIR-126 | Phase 1 | Preeclampsia | – |
Preeclampsia (1)
other (1)
Universitas Padjadjaran (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.